This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Review of the Literature and a Report of Ninety-Seven Cases, With a Note on Streptomycin Therapy

LYDIA MARSHAK, M.D.; ROBERT L. BARTON, M.D.; THEODORE J. BAUER, M.D.

Arch Derm Syphilol. 1948;57(5):858-867.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE LARGE shifts of population which accompanied the recent war created a hitherto unprecedented number of cases of granuloma in the North. Thus, in the space of three years, in the city of Chicago, where the disease was a relative rarity, almost 100 patients were seen and treated at the Chicago Intensive Treatment Center. It appears timely, in view of the large increase in the number of cases seen in northern cities recently, to review the literature on this disease, with particular attention to the newer methods of treatment.

McLeod¹ in India first described the disease as a "serpiginous ulceration of the genitals," and Conyers and Daniels² in 1896 first recognized the disease as a distinct clinical entity. In 1905 Donovan³ in India demonstrated the organism which today bears his name. In 1913 Aragao and Vianna⁴ introduced antimony potassium tartrate in the treatment of the disease. . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO; DUBUQUE, IOWA; Senior Surgeon, United States Public Health Service CHICAGO

From the Chicago Intensive Treatment Center, Venereal Disease Control Program, Chicago Board of Health, in cooperation with the United States Public Health Service.

Footnotes
Under the direction of Herman N. Bundesen, Senior Surgeon (R), United States Public Health Service (Inactive), President, Chicago Board of Health.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?